IONIS PHARMACEUTICALS INC Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Ionis Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • Ionis Pharmaceuticals Inc Interest Expense for the quarter ending June 30, 2024 was $4.49M, a 96% increase year-over-year.
  • Ionis Pharmaceuticals Inc Interest Expense for the twelve months ending June 30, 2024 was $17.4M, a 124% increase year-over-year.
  • Ionis Pharmaceuticals Inc annual Interest Expense for 2023 was $12.7M, a 55.9% increase from 2022.
  • Ionis Pharmaceuticals Inc annual Interest Expense for 2022 was $8.12M, a 13.1% decline from 2021.
  • Ionis Pharmaceuticals Inc annual Interest Expense for 2021 was $9.35M, a 1.69% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.7M +$4.54M +55.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 $8.12M -$1.23M -13.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $9.35M -$161K -1.69% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $9.51M -$2.93M -23.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $12.4M -$32.3M -72.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $44.8M +$37K +0.08% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $44.8M +$5.96M +15.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $38.8M +$2.06M +5.62% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $36.7M +$14.5M +65.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $22.2M +$2.85M +14.7% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $19.4M -$1.8M -8.5% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $21.2M +$4.42M +26.4% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $16.7M +$3.5M +26.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 $13.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.